Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?
The number of patients undergoing allogeneic hematopoietic cell transplantation (HCT) for treatment of malignant and nonmalignant disorders has continued to grow worldwide. (footnotes) Great progress has been made in overcoming HLA/immunologic barriers, but nondonor barriers to HCT persist.(footnote) This represents a major unmet need because HCT is not accessible to everyone who would benefit from it.(footnote)
Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents
Journal Title:
Leukemia & Lymphoma
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):
The evolving role of next generation sequencing in myelodysplastic syndromes
Journal Title:
British Journal of Haematology
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes
Journal Title:
Blood Advances
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Journal Title:
Annals of Hematology
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
Journal Title:
JCO Precision Oncology
Original Publication Date:
Sep 2019
PURPOSE:
Bone Marrow Disease(s):
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
Journal Title:
American Journal of Hematology
Original Publication Date:
Nov 2019
Bone Marrow Disease(s):
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency
Journal Title:
The Journal of Clinical Investigation
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years
Journal Title:
Blood Advances
Original Publication Date:
Oct 2019
Bone Marrow Disease(s):